Triple marker CD44hiCD133+ CD117+ cells possessed potent tumor initiating capacities, indicating that CD44hi CD133+ CD117+ could be used as a robust marker for T-IC identification in salivary gland tumors. The gene discussed is KIT; the disease is neoplasm.